Miniatura

Fitxers

chaccour2015_1863.pdf (1.03 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2015-03-05

Llicència de publicació

cc by (c) Chaccour et al., 2015
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/68726

Screening for an ivermectin slow-release formulation suitable for malaria vector control

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

http://dx.doi.org/10.1186/s12936-015-0618-2

Resum

BACKGROUND: The prospect of eliminating malaria is challenged by emerging insecticide resistance and vectors with outdoor and/or crepuscular activity. Ivermectin can simultaneously tackle these issues by killing mosquitoes feeding on treated animals and humans. A single oral dose, however, confers only short-lived mosquitocidal plasma levels. METHODS: Three different slow-release formulations of ivermectin were screened for their capacity to sustain mosquito-killing levels of ivermectin for months. Thirty rabbits received a dose of one, two or three silicone implants containing different proportions of ivermectin, deoxycholate and sucrose. Animals were checked for toxicity and ivermectin was quantified periodically in blood. Potential impact of corresponding long-lasting formulation was mathematically modelled. RESULTS: All combinations of formulation and dose released ivermectin for more than 12 weeks; four combinations sustained plasma levels capable of killing 50% of Anopheles gambiae feeding on a treated subject for up to 24 weeks. No major adverse effects attributable to the drug were found. Modelling predicts a 98% reduction in infectious vector density by using an ivermectin formulation with a 12-week duration. CONCLUSIONS: These results indicate that relatively stable mosquitocidal plasma levels of ivermectin can be safely sustained in rabbits for up to six months using a silicone-based subcutaneous formulation. Modifying the formulation of ivermectin promises to be a suitable strategy for malaria vector control.

Matèries

Malària, Medicina preventiva, Insectes vectors, Antihelmíntics

Matèries (anglès)

Malaria, Preventive medicine, Insects as carriers of disease, Anthelmintics

Citació

Col·leccions

Articles publicats en revistes (ISGlobal)

Citació

CHACCOUR, Carlos, IRIGOYEN BARRIO, Ángel, ROYO, Ana gloria, MARTINEZ URBISTONDO, Diego, SLATER, Hannah, HAMMANN, Felix, POZO, José luis del. Screening for an ivermectin slow-release formulation suitable
                for malaria vector control. _Malaria Journal_. 2015. Vol. 14, núm. 102. [consulta: 23 de gener de 2026]. ISSN: 1475-2875. [Disponible a: https://hdl.handle.net/2445/68726]

Exportar metadades

JSON - METS

Compartir registre